DRGVX | VIVAX | DRGVX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 32 years | - |
Gain YTD | 22.104 | 19.148 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.16B | 184B | 4% |
Annual Yield % from dividends | 0.90 | 2.25 | 40% |
Returns for 1 year | 24.21 | 27.17 | 89% |
Returns for 3 years | 2.03 | 22.68 | 9% |
Returns for 5 years | 39.99 | 52.39 | 76% |
Returns for 10 years | 22.22 | 114.10 | 19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSSQX | 73.39 | N/A | N/A |
Goldman Sachs US Equity Insights A | |||
NDGCX | 21.80 | -0.14 | -0.64% |
Neuberger Berman Dividend Growth C | |||
IAUYX | 28.28 | -0.24 | -0.84% |
Invesco Dividend Income Y | |||
GMAZX | 15.15 | -0.22 | -1.43% |
GMO International Opportunistic Val IV | |||
REREX | 56.17 | -0.85 | -1.49% |
American Funds Europacific Growth R4 |